1. Home
  2. SXC vs VOR Comparison

SXC vs VOR Comparison

Compare SXC & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$6.14

Market Cap

555.4M

Sector

Industrials

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$16.05

Market Cap

755.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXC
VOR
Founded
1960
2015
Country
United States
United States
Employees
848
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.4M
755.7M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
SXC
VOR
Price
$6.14
$16.05
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$9.00
$45.44
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
04-29-2026
05-13-2026
Dividend Yield
7.58%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,600,300,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.30
N/A
52 Week Low
$5.52
$0.13
52 Week High
$9.82
$49.95

Technical Indicators

Market Signals
Indicator
SXC
VOR
Relative Strength Index (RSI) 43.05 55.16
Support Level $5.52 $11.38
Resistance Level $6.90 $16.88
Average True Range (ATR) 0.21 1.63
MACD -0.00 0.05
Stochastic Oscillator 3.08 50.81

Price Performance

Historical Comparison
SXC
VOR

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: